Rothschild raised its target, and FactSet reports a favorable average analyst rating with an average target of about $742. These opinions support TMO, though they report no change in company sales or profit.
The raised target adds a favorable opinion about Thermo Fisher's prospects. FactSet's average analyst rating points in the same direction. Still, these are analyst views, not new sales or profit results.
Follow Thermo Fisher Scientific (TMO) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TMO